Speech-Language Pathologists in 7146 Nolensville Rd, TN Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Lyndi Roecker Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Project Play Therapy, 7146 Nolensville Rd, TN 37135 Phone: 615-283-6150 |
News Archive
Exercise program during adjuvant breast cancer treatment may provide cardiovascular benefits
Women who underwent a supervised program of cardiovascular exercise during adjuvant breast cancer treatment experienced better cardiovascular function than those who were not part of the exercise program, according to results of the EBBA-II trial presented at the 2018 San Antonio Breast Cancer Symposium, held Dec. 4-8.
Today's opinions and editorials
[I]t's virtually impossible to design a reform scheme that doesn't, in the early stages, involve at least some transfer of money away from the healthy and wealthy. The point of insurance is to pool risk, bringing in contributions from relatively healthy people, so that medical bills don't fall too heavily on the sick (Jonathan Cohn, 12/7).
Nanomedicine Award winners officially announced at BIO-Europe conference
The winners of the first ever Nanomedicine Award were officially announced during the Nanomedicine Panel at BIO-Europe conference in Vienna, November 4th 2013. The Award review Board agreed to distinguish two projects in two different categories: The winners are Endomagnetics Ltd in the nanodiagnostic category and the I-CARE project from Linköping University in the regenerative medicine category.
Articles examine use of mobile phones for global health
The Economist examines how mobile phones could be used to detect the spread of diseases worldwide. According to the Economist, "[t]he world's 4 billion mobile phones could be turned into sensors on a global data-collection network" and aid workers, engineers and several other professionals "are now building systems that use handsets to sense, monitor and even predict population movements, environmental hazards and public-health threats."
Neurocrine Biosciences to sell common stock shares
Neurocrine Biosciences, Inc. today announced that it is offering to sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is the sole book-running manager for this offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
› Verified 1 days ago